Clinical Trials Logo

Clinical Trial Summary

Congenital lung anomalies include different pathologies such as congenital cystic adenomatoid malformation, pulmonary sequestration, bronchial atresia, emphysema, bronchogenic cyst. They concern less than 1/10000 births and their physiopathological origin is still poorly understood. The main goal of this project is to pool the cases from different swiss centers on a prospective cohort study, first to increase knowledge of clinical and radiological evolution and their correlation with histological data, and second to analyse the pathological embryological mechanism underlying these malformations.


Clinical Trial Description

1. To register prospectively clinical, biological, radiological and histological datas in a multicentric database (secured internet link, via Secutrial® software). for children with prenatal diagnosis of this kind of malformation. This study is conducted by a multidisciplinary team, involving obstetricians, neonatologists, pneumologists, pediatric surgeons, radiologists and anatomopathologists.

2. To create a tissue biobank

Outcomes:

1. Contribute to the definition of a standardized procedure at the Swiss level for the treatment of patients suffering from these malformations,

2. Improve the assessment of lesion evolution related to CLA, and

3. Possibly validate some biomarkers, which could help to identify individuals at risk. On the long term, these results could also support the development of innovative therapies targeting the factors involved in lung development. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03044769
Study type Observational [Patient Registry]
Source University Hospital, Geneva
Contact Isabelle Ruchonnet-Métrailler, MD PhD
Email isabelle.ruchonnet-metrailler@hcuge.ch
Status Recruiting
Phase
Start date April 1, 2016
Completion date April 1, 2026

See also
  Status Clinical Trial Phase
Completed NCT02452554 - Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma Phase 2
Completed NCT01353300 - Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer N/A
Completed NCT00565903 - Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome
Completed NCT03044834 - Review of the Paediatric Pleuropulmonary Blastoma French Series
Recruiting NCT01247597 - DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Recruiting NCT03382158 - International PPB/DICER1 Registry
Active, not recruiting NCT01464606 - International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry N/A